Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker
Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday, marking the end of the...
Read MoreLori Lyons-Williams
Company: Abdera TherapeuticsTitle: President & CEOIndustry: PharmaceuticalsNotable in 2024: Lyons-Williams advanced Abdera's precision lung cancer...
Read MoreSpa rules for on next visit including one thing you should never bring with you
Whether you're visiting for a facial, a full-body massage or simply to spend an afternoon by the pool, spas have become the ultimate sanctuary for...
Read MoreAfter Democrats Accused Trump of Wanting To Ban IVF, President Expands Access to Procedure
President Donald Trump signed an executive order on Tuesday to expand access to in vitro fertilization services, fulfilling a campaign promise and...
Read MoreEnd of content
No more pages to load